首頁 > 市場調查報告書 > 醫療設備

體外診斷呼吸器

呼吸系統疾病檢測市場規模、佔有率和成長分析（按檢測類型、應用和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1904414

呼吸系統疾病檢測市場規模、佔有率和成長分析（按檢測類型、應用和地區分類）—2026-2033年產業預測

Respiratory Disease Testing Market Size, Share, and Growth Analysis, By Test Type (Mechanical Tests, Imaging Tests), By Application (Lung Cancer, Asthma), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，呼吸系統疾病檢測市場規模將達到 84.6 億美元，到 2025 年將達到 91.8 億美元，到 2033 年將達到 176.4 億美元，在預測期（2026-2033 年）內複合年成長率為 8.5%。

全球呼吸系統疾病檢測市場正經歷強勁成長，這主要受空氣污染和人口老化等因素導致氣喘、慢性阻塞性肺病（COPD）和肺癌等疾病發病率上升的推動。分子診斷、免疫檢測和影像技術的進步使得早期檢測和個人化治療方法方案成為可能，從而推動了對精準高效診斷方法的需求激增。尤其是在新冠疫情期間，呼吸系統疾病檢測的重要性日益凸顯，人們對包括PCR檢測和抗原檢測在內的各種檢測方法的依賴性也隨之增強。然而，高昂的檢測成本、發展中地區基礎設施有限以及監管障礙等挑戰仍需克服，才能最大限度地發揮市場潛力。開展教育和提高公眾意識的活動對於促進檢測方案的廣泛應用和改善患者就醫途徑至關重要。

呼吸系統疾病檢測市場促進因素

氣喘、慢性阻塞性肺病（COPD）和肺癌等呼吸系統疾病的發生率和盛行率不斷上升，顯著推動了呼吸系統疾病檢測市場的發展。環境污染、吸菸和人口老化等因素加劇了這些疾病帶來的全球性挑戰，凸顯了可靠有效的檢測解決方案的必要性。隨著對精準診斷需求的不斷成長，醫療服務提供者和患者都在尋求先進的檢測方法來應對呼吸系統疾病帶來的負擔，這既展現了市場成長潛力，也凸顯了製定創新醫療策略以解決這些健康問題的緊迫性。

呼吸系統疾病檢測市場的限制因素

由於法規結構複雜且新檢測技術需要嚴格的核准程序，呼吸系統疾病檢測市場面臨許多挑戰。這些嚴格的法規可能對市場參與企業構成重大障礙，因為獲得必要的核准通常需要高成本大量時間和成本。這些延誤會阻礙創新產品的及時上市，最終阻礙呼吸系統疾病診斷技術的進步，並限制市場成長潛力。總而言之，監管合規的複雜性可能成為企業推出新型和改進型呼吸系統疾病檢測解決方案的一大阻礙因素。

呼吸系統疾病檢測市場趨勢

呼吸系統疾病檢測市場正呈現顯著的趨勢，即採用即時檢測解決方案。這一趨勢的驅動力在於對快速診斷的需求日益成長，尤其是在重症監護室和資源匱乏地區，患者需要能夠在床邊直接進行治療決策。對及時準確結果的需求不斷成長，促使醫療機構採用先進的照護現場設備和平台，從而改善患者預後並簡化臨床工作流程。隨著醫療體系的不斷發展，對快速且有效率檢測方法的關注必將改變呼吸系統疾病診斷領域，並成為該市場的關鍵成長點。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Beckton Dickinson and Company
Koninklijke Philips NV
ResMed Inc.
Medtronic
MG Diagnostic Corporation
Abbott
ThermoFisher Scientific
Biomerieux
QIAGEN
Seimens Healthineers AG
F. Hoffmann-La Roche Ltd
SDI Diagnostics
BD
Niterra Co., Ltd.
QuantuMDx Group Ltd.
COSMED srl
Bird Healthcare
visby medical
Seegene Inc
Bio-Rad Laboratories Inc

結論與建議

簡介目錄

Product Code: SQMIG35A2825

Respiratory Disease Testing Market size was valued at USD 8.46 Billion in 2024 and is poised to grow from USD 9.18 Billion in 2025 to USD 17.64 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The global respiratory disease testing market is witnessing robust growth, fueled by rising incidences of conditions like asthma, COPD, and lung cancer, driven by factors such as pollution and an aging population. The demand for precise and efficient diagnostic methods has surged, supported by technological advancements in molecular diagnostics, immunoassays, and imaging techniques, enabling early detection and tailored treatment options. Notably, the COVID-19 pandemic has elevated the importance of respiratory testing, prompting an increased reliance on various testing modalities, including PCR and antigen tests. However, challenges such as high testing costs, limited infrastructure in developing regions, and regulatory hurdles must be addressed to maximize market potential. Education and awareness initiatives are crucial to encourage widespread adoption and improve patient access to testing solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Respiratory Disease Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Respiratory Disease Testing Market Segments Analysis

Global Respiratory Disease Testing Market is segmented by test type, application, end-use and region. Based on test type, the market is segmented into mechanical tests, imaging tests and in-vitro diagnostic tests. Based on application, the market is segmented into chronic obstructive pulmonary disease, lung cancer, asthma, tuberculosis and other. Based on end-use, the market is segmented into hospital, physicians clinic and clinical laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Respiratory Disease Testing Market

The increasing occurrence and frequency of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and lung cancer, significantly propel the respiratory disease testing market. Contributing elements such as environmental pollution, tobacco use, and an aging demographic intensify the global challenge posed by these conditions, underscoring the necessity for reliable and effective testing solutions. As the demand for accurate diagnostics rises, healthcare providers and patients alike seek advanced testing methods to address the burden of respiratory illnesses, highlighting the market's growth potential and the urgent need for innovative healthcare strategies to combat these health issues.

Restraints in the Respiratory Disease Testing Market

The Respiratory Disease Testing market faces significant challenges due to the intricate regulatory frameworks and rigorous approval procedures required for new testing technologies. These stringent regulations can create substantial obstacles for market participants, as securing necessary approvals often involves lengthy and costly processes. Such delays can hinder the timely launch of innovative products, ultimately stifling advancements in respiratory disease diagnostics and limiting the growth potential of the market. Overall, the complexities surrounding regulatory compliance can serve as a considerable restraint for companies aiming to introduce new and improved testing solutions for respiratory diseases.

Market Trends of the Respiratory Disease Testing Market

The Respiratory Disease Testing market is witnessing a significant trend towards the proliferation of point-of-care testing solutions. This shift is fueled by an increasing need for rapid diagnostics that enable immediate treatment decisions directly at the bedside, particularly in critical care settings and areas with limited resources. The demand for timely and precise results is prompting healthcare providers to adopt advanced point-of-care devices and platforms, thereby enhancing patient outcomes and streamlining clinical workflows. As healthcare systems evolve, the focus on quick and efficient testing methods is set to transform the landscape of respiratory diagnostics, making it a key area of growth within the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies

Global Respiratory Disease Testing Market Size by Test Type & CAGR (2026-2033)

Market Overview
Mechanical Tests
- Spirometry
- Peak-Flow Test
- Pulmonary Function Test
- Blood Gas Test
- Others
Imaging Tests
- X-Ray
- Ct-Scan
- Ultrasonography
- Mri
In-Vitro Diagnostic Tests
- Point-Of-Care Test
- Molecular Diagnostic Test

Global Respiratory Disease Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Chronic Obstructive Pulmonary Disease
Lung Cancer
Asthma
Tuberculosis
Other

Global Respiratory Disease Testing Market Size by End-Use & CAGR (2026-2033)

Market Overview
Hospital
Physicians Clinic
Clinical Laboratories

Global Respiratory Disease Testing Market Size & CAGR (2026-2033)

North America (Test Type, Application, End-Use)
- USA
- Canada
Europe (Test Type, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Beckton Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ResMed Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MG Diagnostic Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ThermoFisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seimens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SDI Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Niterra Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuantuMDx Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
COSMED srl
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bird Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
visby medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments